Endothelium-derived relaxing factor (EDRF) is a recently discovered paracrine hormone released from the endothelium lining the vasculature. EDRF has been shown to affect the renal vasculature, but a direct action on individual nephron segments has not been reported to date. Our hypothesis is that EDRF produced by renal endothelial cells inhibits fluid and sodium transport in the collecting duct system. This is based on 1) our preliminary data showing the EDRF inhibits transport in cultured collecting duct cells; 2) the proximity of renal vessels and nephrons; and 3) the fact that EDRF stimulates cGMP production in vascular tissue and CGMP inhibits transport in the collecting duct.
Our specific aims are to investigate: 1) the effects of EDRF on basal sodium and water transport; 2) vasopressin-stimulated transport of sodium and water; 3) if cGMP is the second messenger of EDRF; 4) the roles of protein kinases and phosphodiesterases in mediating the effects; and 5) if the sodium channel is phosphorylated in response to EDRF. We will use a variety of techniques including measurement of transepithelial fluxes of sodium and water; assay of cyclic nucleotides, kinases and phosphodiesterases; immunoprecipitation of the amiloride-sensitive sodium channel and Western blot analysis. The collecting duct system plays a pivotal role in the regulation of solute and water excretion and consequently blood pressure. EDRF may prove to be one of the most important regulators of collecting duct function and yet there is a paucity of data concerning the effects of EDRF on transport in this segment of the nephron.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Modified Research Career Development Award (K04)
Project #
5K04HL002891-05
Application #
2415456
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1993-05-14
Project End
1998-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Henry Ford Health System
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Ren, Y; Yu, H; Wang, H et al. (2001) Nystatin and valinomycin induce tubuloglomerular feedback. Am J Physiol Renal Physiol 281:F1102-8
Plato, C F; Shesely, E G; Garvin, J L (2000) eNOS mediates L-arginine-induced inhibition of thick ascending limb chloride flux. Hypertension 35:319-23
Plato, C F; Pollock, D M; Garvin, J L (2000) Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release. Am J Physiol Renal Physiol 279:F326-33
Plato, C F; Garvin, J L (1999) Nitric oxide, endothelin and nephron transport: potential interactions. Clin Exp Pharmacol Physiol 26:262-8
Garcia, N H; Plato, C F; Stoos, B A et al. (1999) Nitric oxide-induced inhibition of transport by thick ascending limbs from Dahl salt-sensitive rats. Hypertension 34:508-13
Garcia, N H; Plato, C F; Garvin, J L (1999) Fluorescent determination of chloride in nanoliter samples. Kidney Int 55:321-5
Plato, C F; Stoos, B A; Wang, D et al. (1999) Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol 276:F159-63
Asano, K; Cortes, P; Garvin, J L et al. (1999) Characterization of the rat mesangial cell type 2 sulfonylurea receptor. Kidney Int 55:2289-98
Garvin, J L; Beierwaltes, W H (1998) Response of proximal tubules to angiotensin II changes during maturation. Hypertension 31:415-20
Yu, H; Carretero, O A; Juncos, L A et al. (1998) Biphasic effect of bradykinin on rabbit afferent arterioles. Hypertension 32:287-92

Showing the most recent 10 out of 21 publications